Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease
NCT01336088Phase 2Completed
- Sponsor
- Addex Therapeutics Ltd
- Start
- Apr 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of dipraglurant in levodopa-induced dyskinesia (LID), sponsored by Addex Therapeutics Ltd. Started Apr 2011; status: completed.
02
Drugs
dipraglurant
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT01336088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336088.